PRCT procept-biorobotics.com Profit After Tax

Corporate emblem and logo of procept-biorobotics.com (PRCT)

PROCEPT BioRobotics is advancing urology through clinic partnerships and physician training. Its own manufacturing facilities in the US ensure supply chain stability, while the expansion of Aquabeam systems drives consumables sales. The GURU.Markets terminal displays a chart of the company's total financial result, where -0.11 serves as the current parameter value, capturing the real-time profit trend.

Net Income: PROCEPT BioRobotics Inc (PRCT) for 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for PROCEPT BioRobotics Corporation (PRCT)

- market value and analyst target forecast:
Stock Price Procept|PRCT - Price Target Chart
- market capitalization data:
Market Valuation Procept|PRCT - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share PROCEPT BioRobotics|PRCT - Company Net Assets|Market Capitalization to Book Value Ratio procept-biorobotics.com|PRCT - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital PROCEPT BioRobotics|PRCT - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient PROCEPT BioRobotics Corp|PRCT - Company Aggregate Debts|Debt to Book Value Procept|PRCT - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings PROCEPT BioRobotics|Quick Liquidity Indicator procept-biorobotics.com
- company profitability and valuation multiples indicators:
PRCT - Net Profit
Fundamental valuation:PRCT, Procept
Flagship merchandise of PROCEPT BioRobotics Inc

This indicator compares strict GAAP standards with actual cash flow, allowing investors to isolate accounting adjustments from actual liquidity in real time. By analyzing the company's profit trends, one can assess the efficiency of PROCEPT BioRobotics (PRCT) assembly lines in the US, where the operational stability of robotic system production converts directly into real financial results, eliminating the risk of paper profits.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|CONMED Corp. - Net Income|Net Profit Pulse Medical PLSE|INMD: Net Income|picardmedical.com - Profit After Payment of Taxes|SRDX: Net Profit|SENS - Net Financial Result|NPCE (NeuroPace Corp) - Net Profit|Net Income Tactile Systems Technology Inc. (TCMD)|Net Income SNWV (Sanuwave Health Inc)|OM (outsetmedical.com) - Final Profit|Company Net Income Electromed ELMD|LNSR - Net Income|AVITA Medical, Inc - Net Profit|Company Net Income Profound Medical Corp.|BDMD: Net Profit|Company Profit EDAP|APYX (Apyx Medical Corp) - Net Profit|IceCure Medical, Ltd. (ICCM) - Net Financial Result|Net Profit LUNG|Net Income telabio.com TELA|Net Profit CTSO (CytoSorbents Corporation)|Net Profit sensushealthcare.com SRTS|ZYXI - Company Net Income|ECOR: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|reshapelifesciences.com (RSLS) - Company Net Income|Profit After Tax SILK (silkroadmed.com)